Precision BioSciences, Inc. (DTIL)
USD 4.13
(-9.83%)
USD 4.13
(-9.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -84.11 Million | -45.75 Million | -10.85 Million | -87.38 Million | -71.01 Million | -51.72 Million |
| Net Income | -42.52 Million | -111.63 Million | -30.6 Million | -109 Million | -92.87 Million | -46.03 Million |
| Depreciation & Amortization | 8.25 Million | 9 Million | 10.19 Million | 9.81 Million | 5.31 Million | 2.35 Million |
| Deferred income taxes | -1.32 Million | - | -6.14 Million | - | 22 Thousand | - |
| Stock-based compensation | 14.04 Million | 19.19 Million | 16.51 Million | 13.78 Million | 8.94 Million | 2.45 Million |
| Change in working capital | -41.48 Million | 24.11 Million | 19.58 Million | -2.01 Million | -2.35 Million | -10.5 Million |
| Other non-cash items | -21.06 Million | 13.57 Million | -20.4 Million | 35 Thousand | 9.94 Million | 14 Thousand |
| Investing Cash Flow | 5.82 Million | -3.31 Million | -5.8 Million | -5.03 Million | -24.66 Million | -15.66 Million |
| Investments in PPE | -2.27 Million | -3.31 Million | -5.8 Million | -5.03 Million | -24.66 Million | -15.67 Million |
| Acquisitions | 8.1 Million | - | - | - | - | 15 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.00 | -3.31 Million | -750 Thousand | - | - | 15 Thousand |
| Financing Cash Flow | 5.38 Million | 94.98 Million | 70.52 Million | 1.32 Million | 173.37 Million | 107.77 Million |
| Debt repayment | - | -19.8 Million | -2.5 Million | - | -39.55 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5.38 Million | 74.34 Million | 60.47 Million | 1.32 Million | 135.18 Million | 171 Thousand |
| Other Financing Activities | 401 Thousand | 40.44 Million | 12.54 Million | 1.32 Million | 77.73 Million | 107.77 Million |
| Accounts receivables | -181 Thousand | -232 Thousand | 9.51 Million | -9.03 Million | -441 Thousand | -523 Thousand |
| Accounts payables | 1.5 Million | 153 Thousand | 867 Thousand | -1.45 Million | 667 Thousand | -673 Thousand |
| Inventory | - | - | 4.3 Million | 8.01 Million | 5.28 Million | -5.94 Million |
| Other working capital | -42.81 Million | 24.18 Million | 4.9 Million | 463 Thousand | -7.86 Million | -3.36 Million |
| Cash at beginning of period | 189.57 Million | 143.66 Million | 89.79 Million | 180.88 Million | 103.19 Million | 62.8 Million |
| Cash at end of period | 116.67 Million | 189.57 Million | 143.66 Million | 89.79 Million | 180.88 Million | 103.19 Million |
| Capital Expenditure | -2.27 Million | -3.31 Million | -5.8 Million | -5.03 Million | -24.66 Million | -15.67 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -72.89 Million | 45.91 Million | 53.86 Million | -91.08 Million | 77.69 Million | 40.39 Million |
| Free Cash Flow | -86.39 Million | -49.07 Million | -16.65 Million | -92.41 Million | -95.68 Million | -67.4 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.42 Million | 32.74 Million | 8.58 Million | -13.43 Million | -42.52 Million | -8.07 Million |
| Depreciation & Amortization | 1.01 Million | 1.38 Million | 1.42 Million | 1.55 Million | 8.25 Million | 2.03 Million |
| Deferred income taxes | - | - | - | -1.48 Million | -1.32 Million | -7.86 Million |
| Stock-based compensation | 3.19 Million | 2.92 Million | 2.9 Million | 2.96 Million | 14.04 Million | 3.1 Million |
| Change in working capital | 64.79 Million | -44.47 Million | -20.32 Million | 2.95 Million | -41.48 Million | -12.67 Million |
| Other non-cash items | -58.49 Million | -2.06 Million | -2.86 Million | -983 Thousand | -21.06 Million | 386 Thousand |
| Investing Cash Flow | -64 Thousand | -28 Thousand | -26 Thousand | 42 Thousand | 5.82 Million | 7.56 Million |
| Investments in PPE | -39 Thousand | -28 Thousand | -86 Thousand | 5000.00 | -2.27 Million | -436 Thousand |
| Acquisitions | -60 Thousand | - | 60 Thousand | 37 Thousand | 8.1 Million | 8 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 35 Thousand | - | 60 Thousand | 7.78 Million | 1.00 | - |
| Financing Cash Flow | 3.73 Million | 702 Thousand | 40.09 Million | 2.82 Million | 5.38 Million | -34 Thousand |
| Debt repayment | -22.5 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.59 Million | 702 Thousand | 40.09 Million | 2.82 Million | 5.38 Million | -138 Thousand |
| Other Financing Activities | 23.64 Million | - | 1.01 Million | 1000.00 | 401 Thousand | 104 Thousand |
| Accounts receivables | 1.37 Million | 183 Thousand | -848 Thousand | 2.59 Million | -181 Thousand | -2.84 Million |
| Accounts payables | -186 Thousand | 120 Thousand | -2.1 Million | 2 Million | 1.5 Million | -51 Thousand |
| Inventory | - | - | - | -3.83 Million | - | 1.29 Million |
| Other working capital | 62.15 Million | -44.77 Million | -17.37 Million | -1.64 Million | -42.81 Million | -11.07 Million |
| Cash at beginning of period | 123.57 Million | 137.76 Million | 116.67 Million | 122.23 Million | 189.57 Million | 137.79 Million |
| Cash at end of period | 121.32 Million | 123.57 Million | 137.76 Million | 116.67 Million | 116.67 Million | 122.23 Million |
| Capital Expenditure | -39 Thousand | -28 Thousand | -86 Thousand | 5000.00 | -2.27 Million | -436 Thousand |
| Effect of forex changes on cash | - | - | - | -51.11 Million | - | 21.49 Million |
| Net cash flow / Change in cash | -2.24 Million | -14.19 Million | 21.08 Million | -5.55 Million | -72.89 Million | -15.56 Million |
| Free Cash Flow | -5.95 Million | -14.89 Million | -19.06 Million | -8.41 Million | -86.39 Million | -23.52 Million |
AVHHL
AMADF
9559
CHR
0HSU
BBTN